Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Self-reported issues with driving in patients with chronic pain.

Fan A, Wilson KG, Acharya M, Cranney A, Buenger U, Marshall S.

PM R. 2012 Feb;4(2):87-95. doi: 10.1016/j.pmrj.2011.10.008. Epub 2012 Jan 20.

PMID:
22264800
2.

Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada.

Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DE, Atkinson SA, Josse RG, Feldman S, Kline GA, Rosen C; Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada.

CMAJ. 2010 Sep 7;182(12):E610-8. doi: 10.1503/cmaj.080663. Epub 2010 Jul 12. Review. No abstract available.

3.

Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary).

Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD; Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada.

CMAJ. 2010 Sep 7;182(12):1315-9. doi: 10.1503/cmaj.091062. Epub 2010 Jul 12. Review. No abstract available.

4.

Supporting safe driving with arthritis: developing a driving toolkit for clinical practice and consumer use.

Vrkljan BH, Cranney A, Worswick J, O'Donnell S, Li LC, GĂ©linas I, Byszewski A, Man-Son-Hing M, Marshall S.

Am J Occup Ther. 2010 Mar-Apr;64(2):259-67.

PMID:
20437913
5.

Osteoporosis knowledge among individuals with recent fragility fracture.

Giangregorio L, Thabane L, Cranney A, Adili A, deBeer J, Dolovich L, Adachi JD, Papaioannou A.

Orthop Nurs. 2010 Mar-Apr;29(2):99-107. doi: 10.1097/NOR.0b013e3181d2436c.

6.

A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents.

Sawka AM, Ismaila N, Cranney A, Thabane L, Kastner M, Gafni A, Woodhouse LJ, Crilly R, Cheung AM, Adachi JD, Josse RG, Papaioannou A.

PLoS One. 2010 Mar 3;5(3):e9515. doi: 10.1371/journal.pone.0009515. Review.

7.

Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA.

Sambrook P, Cranney A, Adachi JD.

Curr Med Res Opin. 2010 Mar;26(3):599-604. doi: 10.1185/03007990903512321.

PMID:
20055751
8.

Acute monoarthritis: what is the cause of my patient's painful swollen joint?

Ma L, Cranney A, Holroyd-Leduc JM.

CMAJ. 2009 Jan 6;180(1):59-65. doi: 10.1503/cmaj.080183. Review. No abstract available.

9.

Factors predicting osteoporosis treatment initiation in a regionally based cohort.

Cranney A, Tsang JF, Leslie WD.

Osteoporos Int. 2009 Sep;20(9):1621-5. doi: 10.1007/s00198-008-0823-8. Epub 2008 Dec 19.

PMID:
19096744
10.

Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review.

O'Donnell S, Cranney A, Horsley T, Weiler HA, Atkinson SA, Hanley DA, Ooi DS, Ward L, Barrowman N, Fang M, Sampson M, Tsertsvadze A, Yazdi F.

Am J Clin Nutr. 2008 Dec;88(6):1528-34. doi: 10.3945/ajcn.2008.26415. Review.

PMID:
19064512
11.

Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls.

O'Donnell S, Moher D, Thomas K, Hanley DA, Cranney A.

J Bone Miner Metab. 2008;26(6):531-42. doi: 10.1007/s00774-008-0868-y. Epub 2008 Nov 1. Review.

PMID:
18979152
12.

Osteoporosis risk perceptions among patients who have sustained a fragility fracture.

Giangregorio L, Dolovich L, Cranney A, Adili A, Debeer J, Papaioannou A, Thabane L, Adachi JD.

Patient Educ Couns. 2009 Feb;74(2):213-20. doi: 10.1016/j.pec.2008.08.001. Epub 2008 Nov 1.

13.

Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.

Moayyedi P, Cranney A.

Am J Gastroenterol. 2008 Oct;103(10):2428-31. doi: 10.1111/j.1572-0241.2008.02031.x. Review.

PMID:
18855852
14.

Risk factors for low BMD in healthy men age 50 years or older: a systematic review.

Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O'Brien CJ, Sawka AM, Khan A, Siminoski K, Tarulli G, Webster D, McGowan J, Adachi JD.

Osteoporos Int. 2009 Apr;20(4):507-18. doi: 10.1007/s00198-008-0720-1. Epub 2008 Aug 29. Review.

15.

Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health.

Cranney A, Weiler HA, O'Donnell S, Puil L.

Am J Clin Nutr. 2008 Aug;88(2):513S-519S. Review.

PMID:
18689393
16.

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.

Cranney A, Wells GA, Yetisir E, Adami S, Cooper C, Delmas PD, Miller PD, Papapoulos S, Reginster JY, Sambrook PN, Silverman S, Siris E, Adachi JD.

Osteoporos Int. 2009 Feb;20(2):291-7. doi: 10.1007/s00198-008-0653-8. Epub 2008 Jul 29.

PMID:
18663402
17.

A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial.

Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM, Harrison MB, Anastassiades T, Grimshaw JM, Graham ID.

Osteoporos Int. 2008 Dec;19(12):1733-40. doi: 10.1007/s00198-008-0669-0. Epub 2008 Jul 16.

PMID:
18629567
18.

Do patients perceive a link between a fragility fracture and osteoporosis?

Giangregorio L, Papaioannou A, Thabane L, DeBeer J, Cranney A, Dolovich L, Adili A, Adachi JD.

BMC Musculoskelet Disord. 2008 Mar 21;9:38. doi: 10.1186/1471-2474-9-38.

19.

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004523. doi: 10.1002/14651858.CD004523.pub3. Review.

PMID:
18254053
20.

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003376. doi: 10.1002/14651858.CD003376.pub3. Review.

PMID:
18254018
21.

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001155. doi: 10.1002/14651858.CD001155.pub2. Review.

PMID:
18253985
22.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

23.

Bisphosphonate therapy for children and adolescents with secondary osteoporosis.

Ward L, Tricco AC, Phuong P, Cranney A, Barrowman N, Gaboury I, Rauch F, Tugwell P, Moher D.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005324. Review.

PMID:
17943849
24.

Is there a new role for angiotensin-converting-enzyme inhibitors in elderly patients?

Cranney A.

CMAJ. 2007 Oct 9;177(8):891-2. No abstract available.

25.

Low bone mineral density and fracture burden in postmenopausal women.

Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD.

CMAJ. 2007 Sep 11;177(6):575-80.

26.

Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial.

Rodger MA, Kahn SR, Cranney A, Hodsman A, Kovacs MJ, Clement AM, Lazo-Langner A, Hague WM; TIPPS investigators.

J Thromb Haemost. 2007 Aug;5(8):1600-6.

27.

WITHDRAWN: Calcium supplementation on bone loss in postmenopausal women.

Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Hamel C, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group; Osteoporosis Research Advisory Group.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004526. Review.

PMID:
17636765
28.

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD004523.

PMID:
17636764
29.

WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis.

Cranney A, Adachi JD, Griffith L, Guyatt G, Krolicki N, Robinson VA, Shea BJ, Wells G.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD003376. Review.

PMID:
17636719
30.

Physicians' intentions and use of three patient decision aids.

Graham ID, Logan J, Bennett CL, Presseau J, O'Connor AM, Mitchell SL, Tetroe JM, Cranney A, Hebert P, Aaron SD.

BMC Med Inform Decis Mak. 2007 Jul 6;7:20.

31.

Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis.

Sawka AM, Boulos P, Beattie K, Papaioannou A, Gafni A, Cranney A, Hanley DA, Adachi JD, Papadimitropoulos EA, Thabane L.

J Clin Epidemiol. 2007 Apr;60(4):336-44. Epub 2006 Oct 23. Review. Erratum in: J Clin Epidemiol. 2008 Aug;61(8):854.

32.

The Canadian Celiac Health Survey.

Cranney A, Zarkadas M, Graham ID, Butzner JD, Rashid M, Warren R, Molloy M, Case S, Burrows V, Switzer C.

Dig Dis Sci. 2007 Apr;52(4):1087-95. Epub 2007 Feb 22.

PMID:
17318390
33.

Could a policy of provision of hip protectors to elderly nursing home residents result in cost savings in acute hip fracture care? The case of Ontario, Canada.

Sawka AM, Gafni A, Boulos P, Beattie K, Papaioannou A, Cranney A, Hanley DA, Adachi JD, Cheung A, Papadimitropoulos EA, Thabane L.

Osteoporos Int. 2007 Jun;18(6):819-27. Epub 2007 Jan 13.

PMID:
17221294
34.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005326. Review.

PMID:
17054253
35.

Identifying wrist fracture patients with high accuracy by automatic categorization of X-ray reports.

de Bruijn B, Cranney A, O'Donnell S, Martin JD, Forster AJ.

J Am Med Inform Assoc. 2006 Nov-Dec;13(6):696-8. Epub 2006 Aug 23.

36.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
37.

Parathyroid hormone for the treatment of osteoporosis: a systematic review.

Cranney A, Papaioannou A, Zytaruk N, Hanley D, Adachi J, Goltzman D, Murray T, Hodsman A; Clinical Guidelines Committee of Osteoporosis Canada.

CMAJ. 2006 Jul 4;175(1):52-9. Review.

38.

Fragility fractures and the osteoporosis care gap: an international phenomenon.

Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD.

Semin Arthritis Rheum. 2006 Apr;35(5):293-305.

PMID:
16616152
39.

Understanding and overcoming the barriers of implementing patient decision aids in clinical practice.

O'Donnell S, Cranney A, Jacobsen MJ, Graham ID, O'Connor AM, Tugwell P.

J Eval Clin Pract. 2006 Apr;12(2):174-81.

PMID:
16579826
40.

An unusual case of an enlarged temporal artery.

Attar SM, Cranney A, Desjardins M, Victor G, Gilberg S.

J Infect. 2006 Oct;53(4):e195-8. Epub 2006 Feb 21.

PMID:
16497380
41.

The impact of a gluten-free diet on adults with coeliac disease: results of a national survey.

Zarkadas M, Cranney A, Case S, Molloy M, Switzer C, Graham ID, Butzner JD, Rashid M, Warren RE, Burrows V.

J Hum Nutr Diet. 2006 Feb;19(1):41-9.

PMID:
16448474
42.

Prospective evaluation of preferences and quality of life in women with hip fractures.

Cranney AB, Coyle D, Hopman WM, Hum V, Power B, Tugwell PS.

J Rheumatol. 2005 Dec;32(12):2393-9.

PMID:
16331770
43.

Driving problems in patients with rheumatoid arthritis.

Cranney AB, Harrison A, Ruhland L, Vaidyanath C, Graham I, Man-Son-Hing M, Jaffey J, Towheed TE, Anastassiades TP, Dwosh II.

J Rheumatol. 2005 Dec;32(12):2337-42.

PMID:
16331759
44.

Celiac disease: evaluation of the diagnosis and dietary compliance in Canadian children.

Rashid M, Cranney A, Zarkadas M, Graham ID, Switzer C, Case S, Molloy M, Warren RE, Burrows V, Butzner JD.

Pediatrics. 2005 Dec;116(6):e754-9.

PMID:
16322131
45.

Evaluation of in-hospital management of fracture risk in older patients: a chart review study of tertiary prevention.

Byszewski AM, Cranney A, Man-Son-Hing M, Azad N, Amos S.

Arch Gerontol Geriatr. 2006 May-Jun;42(3):319-28. Epub 2005 Oct 5.

PMID:
16213039
46.

Cochrane Review on exercise for preventing and treating osteoporosis in postmenopausal women.

Shea B, Bonaiuti D, Iovine R, Negrini S, Robinson V, Kemper HC, Wells G, Tugwell P, Cranney A.

Eura Medicophys. 2004 Sep;40(3):199-209. No abstract available.

47.

Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos).

Sawka AM, Thabane L, Papaioannou A, Gafni A, Ioannidis G, Papadimitropoulos EA, Hopman WM, Cranney A, Hanley DA, Pickard L, Adachi JD; CaMos Investigators.

Osteoporos Int. 2005 Dec;16(12):1836-40. Epub 2005 Aug 18.

PMID:
16133651
48.

Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.

Cranney A, Adachi JD.

Drug Saf. 2005;28(8):721-30. Review.

PMID:
16048357
49.

Rational use of oral bisphosphonates for the treatment of osteoporosis.

Mathoo JM, Cranney A, Papaioannou A, Adachi JD.

Curr Osteoporos Rep. 2004 Mar;2(1):17-23. Review.

PMID:
16036078
50.

Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials.

Sawka AM, Boulos P, Beattie K, Thabane L, Papaioannou A, Gafni A, Cranney A, Zytaruk N, Hanley DA, Adachi JD.

Osteoporos Int. 2005 Dec;16(12):1461-74. Epub 2005 Jul 1. Review.

PMID:
15990949

Supplemental Content

Loading ...
Support Center